HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Nuclear accumulation of HIF-1α is impaired by curcumin, in company with an abatement of cellular factors associated with glucose metabolism under non-hypoxic conditions [102], suggesting the therapeutic potential of curcumin for chronic myelogenous leukemia.